From Mouse to Patient: The Human Trial for Psilocybin and Chemotherapy Nerve Damage
Earlier this year, MD Anderson researchers showed that psilocybin could stop chemotherapy from damaging nerves in mice. Now the same team is testing it in…
Psilocybin
What a 12-Month Follow-Up Actually Tells You About Psilocybin and Depression
A May 2026 trial from Karolinska Institutet gave 35 people with depression a single dose of psilocybin or an active placebo, then kept following them…
Inside the Trip: The Largest Brain-Imaging Study of Psilocybin Ever Done
A five-year Monash University study scanned 62 people on psilocybin while they rested, meditated, listened to music, and watched a movie — and found that…
Psilocybin: The Mushroom Compound That Might Protect Nerves From Chemotherapy
A new study out of MD Anderson Cancer Center found that psilocybin, given to mice before chemotherapy, completely prevented one of cancer treatment’s most stubborn…
One Dose, A Month of Difference: How Psilocybin Leaves a Mark on the Brain
A UCSF and Imperial College London study gave healthy volunteers a single dose of psilocybin and kept measuring their brains for a month afterward —…